Multiple primary malignancies involving lung cancer

被引:64
作者
Li, Feng [1 ,2 ,3 ]
Zhong, Wen-Zhao [2 ,3 ]
Niu, Fei-Yu [1 ,2 ,3 ]
Zhao, Ning [2 ,3 ]
Yang, Jin-Ji [2 ,3 ]
Yan, Hong-Hong [2 ,3 ]
Wu, Yi-Long [2 ,3 ]
机构
[1] Southern Med Univ, Guangzhou 510515, Guangdong, Peoples R China
[2] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou 510080, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Multiple primary malignancies; Lung cancer; Clinical characteristics; Prognosis; PREVIOUSLY TREATED PATIENTS; RETROSPECTIVE ANALYSIS; CLINICAL-FEATURES; FOLLOW-UP; NEOPLASMS; GEFITINIB; RISK; INSTITUTION; REPAIR; TURKEY;
D O I
10.1186/s12885-015-1733-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades. However, the clinical characteristics and prognosis of MPM patients involving lung cancer were not fully elucidated. This retrospective study was designed to explore the clinical characteristics and prognosis of MPM patients involving lung cancer in the People's Republic of China. Methods: Of 5405 lung cancer cases diagnosed at the Guangdong Lung Cancer Institute between 2005 and 2013, we analyzed 185 patients (3.4 %) with MPM involving lung cancer. Results: Among 185 patients with MPM involving lung cancer, 10 (5.4 %) had three malignancies and 175 (94.6 %) had two malignancies. 10 patients with three malignancies were excluded from the analysis to avoid misunderstanding. Of 175 accompanying malignancies, 64 (36.6 %) were synchronous MPM patients and 111 (63.4 %) were metachronous MPM patients; 49 (28.0 %) were lung cancer first MPM patients and 126 (72.0 %) were other cancer first MPM patients. The most frequent accompanying malignancy was colon cancer (25/175), followed by rectal cancer (18/175), esophageal cancer (17/175), and thyroid cancer (13/175). Metachronous MPM patients showed significantly better overall survival (OS) than synchronous MPM, with a median OS of 72.8 (range 12.2-391.0) and 12.9 (range 0.8-86.3) months, respectively (P < 0.001). Cox regression analysis revealed that time of occurrence and stage were independent factors for OS. Conclusions: Colorectal cancer, esophageal cancer, and thyroid cancer were the tumors that most frequently accompanying lung cancer. Metachronous MPM patients showed significantly better OS compared with synchronous MPM patients.
引用
收藏
页数:8
相关论文
共 32 条
[1]   Multiple Primary Malignancies - A Retrospective Analysis at a Single Center in Turkey [J].
Arpaci, Erkan ;
Tokluoglu, Saadet ;
Yetigyigit, Tarkan ;
Alkis, Necati .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (02) :769-773
[2]   Multiple primary neoplasms at a single institution - Differences between synchronous and metachronous neoplasms [J].
Aydiner, A ;
Karadeniz, A ;
Uygun, K ;
Tas, S ;
Tas, F ;
Disci, R ;
Topuz, E .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (04) :364-370
[3]   High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the late effects study group [J].
Bhatia, S ;
Yasui, Y ;
Robison, LL ;
Birch, JM ;
Bogue, MK ;
Diller, L ;
DeLaat, C ;
Fossati-Bellani, F ;
Morgan, E ;
Oberlin, O ;
Reaman, G ;
Ruymann, FB ;
Tersak, J ;
Meadows, AT .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) :4386-4394
[4]   New Approach to Cancer Therapy Based on a Molecularly Defined Cancer Classification [J].
Cortes, Javier ;
Calvo, Emiliano ;
Vivancos, Ana ;
Perez-Garcia, Jose ;
Angel Recio, Juan ;
Seoane, Joan .
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (01) :70-74
[5]   Multiple primary malignant neoplasms - Case report and a comprehensive review of the literature [J].
Demandante, CGN ;
Troyer, DA ;
Miles, TP .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01) :79-83
[6]   Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer [J].
Fukuoka, M ;
Yano, S ;
Giaccone, G ;
Tamura, T ;
Nakagawa, K ;
Douillard, JY ;
Nishiwaki, Y ;
Vansteenkiste, J ;
Kudoh, S ;
Rischin, D ;
Eek, R ;
Horai, T ;
Noda, K ;
Takata, I ;
Smit, E ;
Averbuch, S ;
Macleod, A ;
Feyereislova, A ;
Dong, RP ;
Baselga, J .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2237-2246
[7]   Multiple Primary Malignant Neoplasms from the Black Sea Region of Turkey [J].
Gursel, B. ;
Meydan, D. ;
Ozbek, N. ;
Ozdemir, O. ;
Odabas, E. .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (02) :667-674
[8]  
Hatta T, 1995, Kyobu Geka, V48, P1101
[9]   Inherited predisposition of lung cancer: A hierarchical modeling approach to DNA repair and cell cycle control pathways [J].
Hung, Rayjean J. ;
Baragatti, Meili ;
Thomas, Duncan ;
McKay, James ;
Szeszenia-Dabrowska, Neonila ;
Zaridze, David ;
Lissowska, Jolanta ;
Rudnai, Peter ;
Fabianova, Eleonora ;
Mates, Dana ;
Foretova, Lenka ;
Janout, Vladimir ;
Bencko, Vladimir ;
Chabrier, Amelie ;
Moullan, Norman ;
Canzian, Federico ;
Hall, Janet ;
Boffetta, Paolo ;
Brennan, Paul .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (12) :2736-2744
[10]  
Irimie A, 2010, J GASTROINTEST LIVER, V19, P69